Changes in expression of human serine protease HtrA1, HtrA2 and HtrA3 genes in benign and malignant thyroid tumors

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1838-1844

  Zurawa Janicka, Dorota ^a   Kobiela, Jarosław ^b   Galczynska, Natalia ^a   Stefaniak, Tomasz ^b   Lipinska, Barbara ^a   Lachinski, Andrzej ^b   Skorko Glonek, Joanna ^a   Narkiewicz, Joanna ^a   Proczko Markuszewska, Monika ^b   Sledzinski, Zbigniew ^b  

^a UNIVERSITY OF GDA SK   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

HtrA serine proteases; TGF 1; Thyroid benign tumors; Thyroid carcinoma

Indexed keywords

PROTEIN HTRA1; PROTEIN HTRA3; SERINE PROTEINASE; SERINE PROTEINASE OMI; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HTRA1 GENE; HTRA2 GENE; HTRA3 GENE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MOLECULAR PATHOLOGY; ONCOGENE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; TISSUE CHARACTERIZATION;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA; HUMANS; MITOCHONDRIAL PROTEINS; RNA, MESSENGER; SERINE ENDOPEPTIDASES; THYROID NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84866458385     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1988     Document Type: Article

References (49)

1. Fassnacht M, Kreissl MC, Weismann D and Allolio B: New targets and therapeutic approaches for endocrine malignancies. Pharmacol Ther 123: 117-141, 2009.
2. Urken ML: Management of well-differentiated thyroid cancer in 2010: perspectives of a head and neck surgical oncologist. Endocr Pract 16: 903-912, 2010.
3. Kapur U and Wojcik EM: Follicular neoplasm of the thyroid-vanishing cytologic diagnosis? Diagn Cytopathol 35: 525-528, 2007. (Pubitemid 47267519)
4. Freitas BC and Cerutti JM: Genetic markers differentiating follicular thyroid carcinoma from benign lesions. Mol Cell Endocrinol 321: 77-85, 2010.
5. Clausen T, Southan C and Ehrmann M: The HtrA family of proteases implications for protein composition and cell fate. Mol Cell 10: 443-455, 2002. (Pubitemid 35284166)
6. Zurawa-Janicka D, Skorko-Glonek J and Lipińska B: HtrA proteins as targets in therapy of cancer and other diseases. Expert Opin Ther Targets 14: 665-679, 2010.
7. Chien J, Campioni M, Shridhar V and Baldi A: HtrA serine proteases as potential therapeutic targets in cancer. Curr Cancer Drug Targets 9: 451-468, 2009.
8. Zumbrumm J and Treub B: Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett 398: 187-192, 1996.
9. Baldi A, De Luca A, Morini M, Battista T, Felsani A, Baldi F, Catricala C, Amantea A, Noonan DM, Albini A, et al: The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells. Oncogene 21: 6684-6688, 2002. (Pubitemid 35177048)
10. Chien J, Staub J, Hu SI, Erickson-Johnson MR, Couch FJ, Smith DI, Crowl RM, Kaufmann SH and Shridhar V: A candidate tumor suppressor HtrA1 is down-regulated in ovarian cancer. Oncogene 23: 1636-1644, 2004. (Pubitemid 38406528)
11. Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, et al: Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. J Clin Invest 116: 1994-2004, 2006. (Pubitemid 44033323)
12. Narkiewicz J, Klasa-Mazurkiewicz D, Zurawa-Janicka D, Skorko-Glonek J, Emerich J and Lipińska B: Changes in expression of human HtrA1, HtrA2 and HtrA3 genes in ovarian cancer. Clin Biochem 41: 561-569, 2008.
13. Bowden MA, Di Nezza-Cossens LA, Jobling T, Salamonsen LA and Nie G: Serine proteases HtrA1 and HtrA3 are down-regulated with increasing grades of human endometrial cancer. Gynecol Oncol 103: 253-260, 2006. (Pubitemid 44374697)
14. Narkiewicz J, Lapińska-Szumczyk S, Zurawa-Janicka D, Skorko-Glonek J, Emerich J and Lipińska B: Expression of human HtrA1, HtrA2, HtrA3 and TGF-β1 genes in primary endometrial cancer. Oncol Rep 21: 1529-1537, 2009.
15. Esposito V, Campioni M, De Luca A, Spugnini EP, Baldi F, Cassandro R, Mancini A, Vincenzi B, Groeger A, Caputi M and Baldi A: Analysis of HtrA1 serine protease expression in human lung cancer. Anticancer Res 26: 3455-3459, 2006. (Pubitemid 44701522)
16. Kotliarow Y, Steed ME, Christopher N, Walling J, Su Q, Center A, Heiss J, Rosenblum M, Mikkelsen T, Zenklusen JC and Fine HA: High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alterations and allelic imbalances. Cancer Res 66: 9428-9436, 2006. (Pubitemid 44623639)
17. Baldi A, Mottolese M, Vincenzi B, Campioni M, Mellone P, Di Marino M, di Crescenzo VG, Visca P, Menegozzo S, Spugnini EP, et al: The serine protease HtrA1 is a novel prognostic factor for human mesothelioma. Pharmacogenomisc 9: 1069-1077, 2008.
18. Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soam A, Kanda H, et al: HtrA1 serine protease inhibits signaling mediated by Tgfß family proteins. Development 131: 1041-1053, 2004. (Pubitemid 38380458)
19. Launay S, Maubert E, Lebeurrier A, Tennstaedt A, Campioni M, Docagne F, Gabriel C, Dauphinot L, Potier MC, Ehrmann M, et al: HtrA1-dependent proteolysis of TGF-β controls both neuronal maturation and development survival. Cell Death Differ 15: 1408-1416, 2008.
20. Inman GJ: Switching TGFβ from a tumor suppressor to a tumor promoter. Curr Opin Genet Dev 21: 93-99, 2011.
21. Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, DoBois G, Lazebnik Y, Zevros AS, Fernandes-Alnemri T and Alnemri ES: Identification of Omi/HtrA2 as mitochondrial apoptotic serine protease that disrupts inhibitors of apoptosis protein-caspase interaction. J Biol Chem 277: 432-438, 2002. (Pubitemid 34952076)
22. Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR, Savopoulos J, Gray CW, Creasy CL, Dingwall C and Downward J: The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 277: 439-444, 2002. (Pubitemid 34952077)
23. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, et al: HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis protein. J Biol Chem 277: 445-454, 2002. (Pubitemid 34952078)
24. Srinivasula SM, Gupta S, Datta P, Zhang Z, Hegde R, Cheong N, Fernandes-Alnemri T and Alnemri ES: Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. J Biol Chem 278: 31469-31472, 2003. (Pubitemid 37048322)
25. Yang QH, Church-Hajduk R, Ren J, Newton ML and Du Ch: Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev 17: 1487-1496, 2003.
26. Seong YM, Choi JY, Park HJ, Kim KJ, Ahn SG, Seong GH, Kim IK, Kang S and Rhim H: Autocatalytic processing of HtrA2/Omi is essential for induction of caspase-dependent cell death through antagonizing XIAP. J Biol Chem 279: 37588-37596, 2004. (Pubitemid 39195472)
27. Trencia A, Fiory F, Maitan MA, Vito P, Barbagallo AP, Perfetti A, Miele C, Ungaro P, Oriente F, Cilenti L, et al: Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea15. J Biol Chem 279: 46566-46572, 2004. (Pubitemid 39518301)
28. Cilenti L, Soundarapandrian MM, Kyriasis GA, Stratico V, Singh S, Gupta S, Bonventre JV, Alnemri ES and Zervos AS: Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 279: 50295-50301, 2004. (Pubitemid 39577845)
29. Liu Z, Li H, Derouet M, Berezkin A, Sasazuki T, Shirasawa S and Rosen K: Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial proapoptotic protein Omi/HtrA2 into the cytoplasm. J Biol Chem 281: 14738-14747, 2006. (Pubitemid 43855179)
30. Simpson CD, Anyiwe K and Schimmer AD: Anoikis resistance and tumor metastasis. Cancer Lett 272: 177-185, 2008.
31. Nie GY, Li Y, Minoura H, Batten L, Ooi GT, Findley JK and Salamonsen LA: A novel serine protease of the mammalian HtrA family is up-regulated in mouse uterus coinciding with plancentation. Mol Hum Reprod 9: 279-290, 2003. (Pubitemid 36748831)
32. Nie GY, Li Y, Hale K, Okada H, Manuelpillai U, Wallace EM and Salamonsen LA: Serine protease HtrA3 is closely associated with human plancetal development and is elevated in pregnancy serum. Biol Reprod 74: 366-374, 2006. (Pubitemid 43122288)
33. Nie G, Hale K, Li Y, Manuelpillai U, Wallace EM and Salamonsen LA: Distinct expression and localization of serine protease HtrA1 in human endometrium and first-trimester plancenta. Dev Dyn 235: 3448-3455, 2006. (Pubitemid 44888211)
34. Nie GY, Hampton A, Li Y, Findlay JK and Salamonsen LA: Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2. Biochem J 371: 39-48, 2003. (Pubitemid 36458077)
35. Tocharus J, Tsuchiya A, Kajikawa M, Ueta Y, Oka C and Kawaichi M: Developmentally regulated expression of Morse HtrA3 and its role as an inhibitor of TGF-β signaling. Dev Growth Differ 46: 257-274, 2004. (Pubitemid 38943090)
36. Beleford D, Rattan R, Chien J and Shridhar V: High-temperature requirement A3 (HtrA3) promotes etoposide- and cisplatin-induced cytotoxicity in lung cancer cell lines. J Biol Chem 285: 12011-12027, 2010.
37. Beleford D, Liu Z, Rattan R, Quagliuolo L, Boccellino M, Baldi A, Maguire J, Staub J, Molina J and Shridhar V: Methylation induced gene silencing of HtrA3 in smoking-related lung cancer. Cancer Res 16: 398-409, 2010.
38. Lipinska B, Zylicz M and Georgopoulos C: The HtrA (DegP) protein, essential for Escherichia coli survival at elevated temperatures, is an endoprotease. J Bacteriol 172: 1791-1797, 1990. (Pubitemid 20111996)
39. Laemmli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
40. Pound JD: Immunochemical protocols. In: Methods in Molecular Biology. Vol 80. Walker JM (ed). Humana Press, Totowa, NJ, 1998.
41. Zurawa-Janicka D, Kobiela J, Stefaniak T, Wozniak A, Narkiewicz J, Limon J, Wozniak M and Lipinska B: Changes in expression of HtrA1 and HtrA2 serine proteases during estrogen-induced oxidative stress and nephrocarcinogenesis in male Syrian hamster. Acta Biochem Polon 55: 9-19, 2008. (Pubitemid 351468917)
42. Hu XY, Xu YM, Chen XC, Ping H, Chen ZH and Zeng FQ: Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia. Acta Pathol Microbiol Immunol Scand 114: 893-898, 2006. (Pubitemid 44967325)
43. Lee SH, Lee JW, Kim HS, Kim SY, Park WS, Kim SH, Lee JY and Yoo NJ: Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer. APMIS 111: 586-590, 2003. (Pubitemid 36963179)
44. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcionomas subclasses. Proc Natl Acad Sci USA 98: 13790-13795, 2001. (Pubitemid 33115977)
45. Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA Chan Z, Bunn PA, Johnson GL, Hirsch FR, Merrick DT, Franklin WA, et al: Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol 167: 1763-1775, 2005. (Pubitemid 41713326)
46. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874, 2001. (Pubitemid 32878711)
47. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et al: Repeated observation of breast tumor subclasses in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418-8423, 2003. (Pubitemid 36842560)
48. Handkiewecz-Junak D, Czarniecka A and Jarzab B: Molecular prognostic markers in papillary and follicular thyroid cancer: current status and future directions. Mol Cell Endocrinol 322: 8-28, 2010.
49. Chien J, Ota T, Aletti G, Shridhar R, Boccellino M, Quagliuolo L, Baldi A and Shridhar V: Serine protease HtrA1 associates with microtubules and inhibits cell migration. Mol Cell Biol 29: 4177-4187, 2009.